Big risk, small risk: Small bowel cancer in Crohn's disease

Inflammatory Bowel Diseases

Volumn 15, Issue 9, 2009, Pages 1434-1435

  Osterman, Mark T ^a  

^a PENN PRESBYTERIAN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 ACETAMIDOSALICYLIC ACID; AZATHIOPRINE; CORTICOSTEROID; INFLIXIMAB; MERCAPTOPURINE; METHOTREXATE;

CANCER RISK; CROHN DISEASE; DISEASE ACTIVITY; DISEASE COURSE; DISEASE DURATION; DRUG USE; ENTERITIS; HUMAN; NOTE; PRIORITY JOURNAL; RISK ASSESSMENT; SMALL INTESTINE CANCER; SMALL INTESTINE RESECTION;

EID: 69449102691     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20888     Document Type: Note

References (11)

1. Ginzburg L, Schneider KM, Dreizin DH, et al. Carcinoma of the jejunum occurring in a case of regional enteritis. Surgery. 1956;39:347-351.
2. Feldstein RC, Sood S, Katz S. Small bowel adenocarcinoma in Crohn's disease. Inflamm Bowel Dis. 2008;14:1154-1157.
3. Palascak-Juif V, Bouvier AM, Cosnes J, et al. Small bowel adenocarcinoma in patients with Crohn's disease compared with small bowel adenocarcinoma de novo. Inflamm Bowel Dis. 2005;11:828-832. (Pubitemid 41368271)
4. Jess T, Gamborg M, Matzen P, et al. Increased risk of intestinal cancer in Crohn's disease: a meta-analysis of population-based cohort studies. Am J Gastroenterol. 2005;100:2724-2729. (Pubitemid 43919641)
5. Canavan C, Abrams KR, Mayberry J. Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease. Aliment Pharmacol Ther. 2006;23:1097-1104. (Pubitemid 43779348)
6. Lashner BA. Risk factors for small bowel cancers in Crohn's disease. Dig Dis Sci. 1992;37:1179-1184.
7. Solem CA, Harmsen WS, Zinsmeister AR, et al. Small intestinal adenocarcinoma in Crohn's disease. A case-control study. Inflamm Bowel Dis. 2004;10:32-35. (Pubitemid 38072443)
8. Jess T, Winther KV, Munkholm P, et al. Intestinal and extra-intestinal cancer in Crohn's disease: follow-up of a population-based cohort in Copenhagen County, Denmark. Aliment Pharmacol Ther. 2004;19:287-293. (Pubitemid 38253503)
9. Velayos F, Terdiman JP, Walsh JM. Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and meta-analysis of observational studies. Am J Gastroenterol. 2005;100:1345-1353. (Pubitemid 40904360)
10. Siegel CA, Sands BE. Risk factors for colorectal cancer in Crohn's colitis: a case-control study. Inflamm Bowel Dis. 2006;12:491-496. (Pubitemid 43916745)
11. Sigel JE, Petras RE, Lashner BA, et al. Intestinal adenocarcinoma in Crohn's disease: a report of 30 cases with a focus on coexisting dysplasia. Am J Surg Pathol. 1999;23:651-655. (Pubitemid 29262827)